Fetal Monitoring Market worth $5.2 billion by 2026
iCrowd Newswire
According to the new market research report by Product (Ultrasound (3D & 4D), Fetal Electrodes, Telemetry Devices, Accessories and Consumables), Portability (Portable Systems), Method (Invasive), Application (Antepartum), End User (Hospitals) - Global Forecast to 2026″, published by MarketsandMarkets™, the market is projected to reach USD 5.2 billion by 2026 from USD 3.7 billion in 2021, at a CAGR of 7.2% from 2021 to 2026.
Browse in-depth TOC on Ultrasound Devices is expected to hold the largest share of the market, by product in 2021.
Based on products, the fetal monitoring market is segmented into ultrasound devices, electronic maternal/fetal monitors, fetal electrodes, fetal doppler devices, uterine contraction monitors, telemetry devices, accessories & consumables, and other products. Ultrasound devices are the largest segment in this market. This segments growth can primarily be attributed to tech
Share this article
Share this article
ResearchAndMarkets.com s offering.
The global cardiac rhythm management devices market size is anticipated to reach USD 29.9 billion by 2028 and is expected to expand at a CAGR of 7.4% from 2021 to 2028.
The market has shown constant growth in the adoption of cardiac rhythm management (CRM) devices owing to the increasing prevalence of cardiovascular disorders. According to the CDC, as of September 2020, approximately 655,000 Americans die suffering from heart disease every year.
The market was negatively impacted during the COVID-19 pandemic, as elective procedures, including the non-essential cardiovascular procedures, were postponed or canceled during the pandemic. Major players in the market, such as Medtronic, Abbott, and Boston Scientific Corporation, incurred huge losses in their cardiac rhythm management business segments globally. This resulted in negative growth of the market in 2020.
Global Cardiac Rhythm Management Devices Markets, 2016-2020 & 2021-2028 prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Global Cardiac Rhythm Management Devices Markets, 2021-2028 - Focus on Pacemaker, Defibrillators, CRT Devices - ResearchAndMarkets.com
April 27, 2021 GMT
DUBLIN (BUSINESS WIRE) Apr 27, 2021
The global cardiac rhythm management devices market size is anticipated to reach USD 29.9 billion by 2028 and is expected to expand at a CAGR of 7.4% from 2021 to 2028.
The market has shown constant growth in the adoption of cardiac rhythm management (CRM) devices owing to the increasing prevalence of cardiovascular disorders. According to the CDC, as of September 2020, approximately 655,000 Americans die suffering from heart disease every year.
Share this article
Share this article
ResearchAndMarkets.com s offering.
The Global Cardiac Monitoring & Cardiac Rhythm Management Market is estimated to be USD 21.6 Bn in 2020 and is expected to reach USD 27.31 Bn by 2025, growing at a CAGR of 4.8%.
Market Dynamics
The increasing instance of cardiovascular disorders is one of the foremost factors driving the cardiac rhythm management devices market. The implantable device technology uses complementary metal-oxide-semiconductor (CMOS) which are vulnerable to damage by the therapeutic doses of radiation, but it can vary according to the type of device in use. This factor is one of the major factors that limits the scope of using cardiac rhythm management devices, as the implants are highly sensitive and their malfunctioning may have serious consequences. On the other hand, the high cost of these devices with limited insurance coverage is limiting the growth of the market.